FERNANDO
ARRIBAS YNSAURRIAGA
Profesor asociado de Ciencias de la Salud
Hospital Morales Meseguer
Murcia, EspañaPublicaciones en colaboración con investigadores/as de Hospital Morales Meseguer (6)
2023
-
Adverse Clinical Outcomes and Associated Predictors in Rivaroxaban-Treated Atrial Fibrillation Patients With Renal Impairment
American Journal of Cardiology, Vol. 203, pp. 122-127
-
Non-embolic outcomes in patients with cardiovascular disease and atrial fibrillation treated with rivaroxaban
Journal of comparative effectiveness research, Vol. 12, Núm. 3, pp. e220049
2022
-
Outcomes and predictive value of the 2MACE score in patients with atrial fibrillation treated with rivaroxaban in a prospective, multicenter observational study: The EMIR study
Cardiology Journal, Vol. 29, Núm. 4, pp. 601-609
-
Predicting performance of the HAS-BLED and ORBIT bleeding risk scores in patients with atrial fibrillation treated with Rivaroxaban: Observations from the prospective EMIR Registry
European heart journal. Cardiovascular pharmacotherapy, Vol. 9, Núm. 1, pp. 38-46
-
Rivaroxaban for the prevention of outcomes in patients with atrial fibrillation in clinical practice: an indirect comparison of national and international registries
Journal of comparative effectiveness research, Vol. 11, Núm. 16, pp. 1173-1184
2013
-
Differential clinical characteristics and prognosis of intraventricular conduction defects in patients with chronic heart failure
European Journal of Heart Failure, Vol. 15, Núm. 8, pp. 877-884